GHI Genomic Health Inc. / Eastern Cooperative Oncology Group / Cox / Quality Assurance Program Pty Ltd / Genomic Health Inc. / /
Continent
Australia / Europe / South America / /
Country
United States / Canada / Australia / /
Currency
pence / Rs / /
Event
FDA Phase / /
Facility
Medical Research Council NICE National Institute / AIHW Australian Institute of Health / The laboratory / Genomic laboratory / Genomic Health laboratory / College of American Pathologists / National Cancer Institute / CAP College / Genomic Health Inc. laboratory / Royal College of Pathologists / /
IndustryTerm
vascular systems / prognostic algorithm / real-time reverse-transcriptase polymerase chain reaction / healthcare / healthcare resource / diagnostic medical devices / ultrasound imaging / therapy for breast cancer / treatment of breast cancer / reproducible technology / healthcare system perspective / healthcare resources / literature search / treatment algorithm / /
MarketIndex
set 250 / /
MedicalCondition
invasive tumours / rat sarcoma / primary breast cancer / metastasis / early breast cancer / node positive disease / ER-positive disease / insufficient invasive tumor / hormone receptor-positive breast cancer / tumour to enable breast / metastatic breast cancer / injury / early stage breast cancer / Breast Cancer TNM / illness / breast cancer / breast tumours / breast tumour / common cancer / cancer / Tumors / total disease / disease / Malignant Tumours uRS / node negative breast cancer / tumour / ER+ breast cancer / invasive breast cancers / invasive carcinoma / invasive breast cancer / distant metastases / B-cell lymphoma / tumours / breast cancer stage I-II / /
AIHW Australian Institute of Health / Royal College of Pathologists of Australasia / College of American Pathologists / Bioanalysts AACR American Association / Ovarian Cancer Centre NCCN National Comprehensive Cancer Network NHMRC National Health and Medical Research Council NICE National Institute for Health / Therapeutic Goods Administration / National Association of Testing Authorities / Medicare / NATA National Association of Testing Authorities NBOCC National Breast / American Joint Committee / ESMO European Society for Medical Oncology FECD / Medical Service / Department of Health / CAP College of American Pathologists CD-68 Cluster / Medical Services Advisory Committee / /
Position
pathologist for examination / physician / RT / General / messenger / Benefits Scheme MDM Multidisciplinary Meeting mRNA messenger / cellular messenger / candidate for chemotherapy / Governor / Health Minister / pathologist / patient/physician / Major / representative / surgeon / Government Health Minister / /
1342 Final Decision Analytical Protocol (DAP) to guide the assessment of gene expression profiling of 21 genes in breast cancer assay to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit